Literature DB >> 23177198

CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV.

Gen Tanaka1, Ikuhiko Nakase, Yasunori Fukuda, Ryo Masuda, Shinya Oishi, Kazuya Shimura, Yoshimasa Kawaguchi, Tomoka Takatani-Nakase, Ulo Langel, Astrid Gräslund, Katsuya Okawa, Masao Matsuoka, Nobutaka Fujii, Yasumaru Hatanaka, Shiroh Futaki.   

Abstract

CXCR4 is a coreceptor of HIV-1 infection in host cells. Through a photocrosslinking study to identify receptors involved in internalization of oligoarginine cell-penetrating peptides (CPPs), we found that CXCR4 serves as a receptor that stimulates macropinocytic uptake of the arginine 12-mer peptide (R12) but not of the 8-mer. We also found that stimulating CXCR4 with its intrinsic ligands, stromal cell-derived factor 1α and HIV-1 envelope glycoprotein 120, induced macropinocytosis. R12 had activity to prevent viral infection for HIV-1(IIIB), a subtype of HIV-1 that uses CXCR4 as a coreceptor for entry into susceptible cells, whereas the addition of a macropinocytosis inhibitor, dimethylamiloride, resulted in enhancement of viral infection. The present study shows that CXCR4 triggers macropinocytosis, which may have implications for the cellular uptake of oligoarginine CPPs and internalization of HIV.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177198     DOI: 10.1016/j.chembiol.2012.09.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  27 in total

Review 1.  Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis.

Authors:  Sasha A Doodnauth; Sergio Grinstein; Michelle E Maxson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

Review 2.  Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cells.

Authors:  Arpan S Desai; Morag R Hunter; Alexander N Kapustin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

3.  CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.

Authors:  Regina Pacitto; Isabella Gaeta; Joel A Swanson; Sei Yoshida
Journal:  J Leukoc Biol       Date:  2016-10-17       Impact factor: 4.962

Review 4.  Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem.

Authors:  Julia C LeCher; Scott J Nowak; Jonathan L McMurry
Journal:  Biomol Concepts       Date:  2017-09-26

5.  Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice.

Authors:  Masa-Aki Shibata; Eiko Shibata; Kentaro Maemura; Yoichi Kondo; Mariko Harada-Shiba
Journal:  Med Mol Morphol       Date:  2017-02-28       Impact factor: 2.309

6.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

7.  Functional Diversity of Macropinocytosis.

Authors:  Rajeev Mishra; Yamini Gupta; Garima Ghaley; Neil A Bhowmick
Journal:  Subcell Biochem       Date:  2022

8.  SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.

Authors:  Sergiy Sukhanov; Yusuke Higashi; Shaw-Yung Shai; Patricia Snarski; Svitlana Danchuk; Veronica D'Ambra; Michael Tabony; T Cooper Woods; Xuwei Hou; Zhaohui Li; Atsufumi Ozoe; Bysani Chandrasekar; Shin-Ichiro Takahashi; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 9.  Chemokines and their receptors in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2015-07-15       Impact factor: 4.599

Review 10.  MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.

Authors:  Emiel P C van der Vorst; Yvonne Döring; Christian Weber
Journal:  Front Immunol       Date:  2015-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.